These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15176874)

  • 61. [Description of the ratios between metabolite concentrations in a polyenzyme system].
    Stefanov VE; Magarshak IuB
    Biofizika; 1979; 24(6):999-1002. PubMed ID: 508840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structural resolution of the complex between a fungal polygalacturonase and a plant polygalacturonase-inhibiting protein by small-angle X-ray scattering.
    Benedetti M; Leggio C; Federici L; De Lorenzo G; Pavel NV; Cervone F
    Plant Physiol; 2011 Oct; 157(2):599-607. PubMed ID: 21859985
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polygalacturonic acid/endo-polygalacturonase system: a kinetic study in batch reactors.
    Gallifuoco A; Cantarella M; Viparelli P; Marucci M
    Biotechnol Prog; 2004; 20(5):1430-6. PubMed ID: 15458327
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Polygalacturonase inhibiting protein in plant cell walls.
    Glinka EM; Protsenko MA
    Biochemistry (Mosc); 1998 Sep; 63(9):1015-20. PubMed ID: 9795270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-throughput screening of enzyme inhibitors: simultaneous determination of tight-binding inhibition constants and enzyme concentration.
    Kuzmic P; Elrod KC; Cregar LM; Sideris S; Rai R; Janc JW
    Anal Biochem; 2000 Nov; 286(1):45-50. PubMed ID: 11038272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A phage display-selected peptide inhibitor of Agrobacterium vitis polygalacturonase.
    Warren JG; Kasun GW; Leonard T; Kirkpatrick BC
    Mol Plant Pathol; 2016 May; 17(4):480-6. PubMed ID: 26177065
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mapping glycans onto specific N-linked glycosylation sites of Pyrus communis PGIP redefines the interface for EPG-PGIP interactions.
    Lim JM; Aoki K; Angel P; Garrison D; King D; Tiemeyer M; Bergmann C; Wells L
    J Proteome Res; 2009 Feb; 8(2):673-80. PubMed ID: 19072240
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Time-dependent closed form solutions for fully competitive enzyme reactions.
    Schnell S; Mendoza C
    Bull Math Biol; 2000 Mar; 62(2):321-36. PubMed ID: 10824432
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kinetic behavior of the general modifier mechanism of Botts and Morales with non-equilibrium binding.
    Jia C; Liu XF; Qian MP; Jiang DQ; Zhang YP
    J Theor Biol; 2012 Mar; 296():13-20. PubMed ID: 22100501
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Purification and Characterization of a Polygalacturonase-Inhibiting Protein from Phaseolus vulgaris L.
    Cervone F; De Lorenzo G; Degrà L; Salvi G; Bergami M
    Plant Physiol; 1987 Nov; 85(3):631-7. PubMed ID: 16665751
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The determination of enzyme inhibitor constants for inhibitors binding strongly to protein or other cell constituents.
    Lloyd JB
    Enzymologia; 1968 Aug; 35(2):75-81. PubMed ID: 4971617
    [No Abstract]   [Full Text] [Related]  

  • 72. SPR and differential proteolysis/MS provide further insight into the interaction between PGIP2 and EPGs.
    Gutierrez-Sanchez G; King D; Kemp G; Bergmann C
    Fungal Biol; 2012 Jul; 116(7):737-46. PubMed ID: 22749160
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Computer simulations of the kinetics of irreversible enzyme inhibition by an unstable inhibitor.
    Topham CM
    Biochem J; 1986 Dec; 240(3):817-20. PubMed ID: 3827869
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simulation of an inhibitory equilibrium system. Aberrant proteinic target sizes as obtained by radiation inactivation.
    Swillens S
    Biochem J; 1984 Aug; 222(1):273-6. PubMed ID: 6477512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Application of a normalised plot to the study of uni-uni enzyme-inhibitor systems.
    Bravo IG; Busto F; De Arriaga D; Ferrero MA; Rodríguez-Aparicio LB; Martínez-Blanco H; Reglero A
    Biochim Biophys Acta; 2002 Jul; 1571(3):183-9. PubMed ID: 12090932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Investigating receptor enzyme activity using time-scale analysis.
    You T; Yue H
    IET Syst Biol; 2015 Dec; 9(6):268-76. PubMed ID: 26577161
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Size determination of an equilibrium enzymic system by radiation inactivation: theoretical considerations.
    Simon P; Swillens S; Dumont JE
    Biochem J; 1982 Sep; 205(3):477-83. PubMed ID: 7150227
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Virtual kinetics: using statistical experimental design for rapid analysis of enzyme inhibitor mechanisms.
    Bronson DD; Daniels DM; Dixon JT; Redick CC; Haaland PD
    Biochem Pharmacol; 1995 Sep; 50(6):823-31. PubMed ID: 7575644
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct simulation of enzyme systems: first results with a direct simulation basic element.
    Schugurensky CM; Olavarria JM
    Acta Physiol Lat Am; 1969; 19(2):153-5. PubMed ID: 5362855
    [No Abstract]   [Full Text] [Related]  

  • 80. Reversible inhibition in bimolecular rapid equilibrium random order enzyme systems. The effect of substrate-substrate and inhibitor-substrate interactions.
    Clark AG
    Biochem J; 1970 May; 117(5):997-1003. PubMed ID: 4989042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.